amitriptylin orifarm 10 mg
orifarm generics a/s - amitriptylinhydroklorid - tablett, filmdrasjert - 10 mg
cardizem retard 90 mg
pfizer as - diltiazemhydroklorid - depottablett - 90 mg
cardizem retard 120 mg
pfizer as - diltiazemhydroklorid - depottablett - 120 mg
cardizem retard 180 mg
pfizer as - diltiazemhydroklorid - depottablett - 180 mg
cardizem uno 180 mg
pfizer as - diltiazemhydroklorid - depottablett - 180 mg
cardizem uno 240 mg
pfizer as - diltiazemhydroklorid - depottablett - 240 mg
cardizem uno 300 mg
pfizer as - diltiazemhydroklorid - depottablett - 300 mg
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
zomarist
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.